Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Analysis of sterol-regulatory element-binding protein 1c target genes in mouse liver during aging and high-fat diet.

Capel F, Rolland-Valognes G, Dacquet C, Brun M, Lonchampt M, Ktorza A, Lockhart B, Galizzi JP.

J Nutrigenet Nutrigenomics. 2013;6(2):107-22. doi: 10.1159/000350751. Epub 2013 Jun 12.

PMID:
23774190
2.

Pharmacometabonomic investigation of dynamic metabolic phenotypes associated with variability in response to galactosamine hepatotoxicity.

Coen M, Goldfain-Blanc F, Rolland-Valognes G, Walther B, Robertson DG, Holmes E, Lindon JC, Nicholson JK.

J Proteome Res. 2012 Apr 6;11(4):2427-40. doi: 10.1021/pr201161f. Epub 2012 Mar 2.

PMID:
22384821
3.

Molecular characterization of the AMPA-receptor potentiator S70340 in rat primary cortical culture: whole-genome expression profiling.

Mourlevat S, Galizzi JP, Guigal-Stéphan N, Courtade-Gaïani S, Rolland-Valognes G, Rodriguez M, Barbet F, Bourrier C, Catesson S, Chomel A, Danober L, Villain N, Caignard DH, Pirotte B, Lestage P, Lockhart BP.

Neurosci Res. 2011 Aug;70(4):349-60. doi: 10.1016/j.neures.2011.05.004. Epub 2011 May 14.

PMID:
21609738
4.

Only a subset of Met-activated pathways are required to sustain oncogene addiction.

Bertotti A, Burbridge MF, Gastaldi S, Galimi F, Torti D, Medico E, Giordano S, Corso S, Rolland-Valognes G, Lockhart BP, Hickman JA, Comoglio PM, Trusolino L.

Sci Signal. 2009;2(102):er11.

PMID:
20039471
5.

Only a subset of Met-activated pathways are required to sustain oncogene addiction.

Bertotti A, Burbridge MF, Gastaldi S, Galimi F, Torti D, Medico E, Giordano S, Corso S, Rolland-Valognes G, Lockhart BP, Hickman JA, Comoglio PM, Trusolino L.

Sci Signal. 2009 Dec 8;2(100):ra80. doi: 10.1126/scisignal.2000643. Erratum in: Sci Signal. 2009 Dec 22;2(102):er11. Corrected and republished in: Sci Signal. 2009;2(102):er11.

6.

Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.

Jaulmes A, Sansilvestri-Morel P, Rolland-Valognes G, Bernhardt F, Gaertner R, Lockhart BP, Cordi A, Wierzbicki M, Rupin A, Verbeuren TJ.

Thromb Res. 2009 Sep;124(4):439-46. doi: 10.1016/j.thromres.2009.05.018. Epub 2009 Jun 21.

PMID:
19540572
7.

Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.

Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E.

Bioorg Med Chem. 2007 Mar 15;15(6):2368-74. Epub 2007 Jan 19.

PMID:
17267227
8.

Semiquantitative analysis of gene expression in cultured chondrocytes by RT-PCR.

Rolland-Valognes G.

Methods Mol Med. 2004;100:69-78.

PMID:
15280588
9.

Effects of transforming growth factor-beta on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro.

Moulharat N, Lesur C, Thomas M, Rolland-Valognes G, Pastoureau P, Anract P, De Ceuninck F, Sabatini M.

Osteoarthritis Cartilage. 2004 Apr;12(4):296-305.

Supplemental Content

Loading ...
Support Center